It means MIDI took money from people who are expecting at least a 5-7 fold return on their investment, a much higher level of growth and profitability than has typically been associated with health care as it has been provided in the past
Phase I dose-escalation study evaluating safety, tolerability and pharmacokinetics of MEDI-573, a dual IGF-I/II neutralizing antibody, in Japanese patients with advanced solid tumours
Lab needs vary by patient, but a physician may monitor A1C, fasting glucose, cholesterol, triglycerides, liver enzymes, kidney function, thyroid markers, inflammatory markers, and nutrient status when appropriate
These are only labeled for those with type 2 diabetes, even though doctors may choose to prescribe these medications off-label to use for weight loss alone